Cormorant Asset Management, LP Phasebio Pharmaceuticals Inc C Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
N/A
-816,448 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
N/A
-89,781 Reduced 9.91%
816,448 $3.41 Million
Q2 2019

Aug 14, 2019
BUY
N/A
66,587 Added 7.93%
906,229 $11.9 Million
Q1 2019

May 15, 2019
SELL
N/A
-258,284 Reduced 23.52%
839,642 $7.99 Million
Q4 2018

Feb 14, 2019
BUY
N/A
1,097,926 New
1,097,926 $3.39 Million

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email